期刊
EMERGING INFECTIOUS DISEASES
卷 21, 期 6, 页码 1041-1044出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2106.140717
关键词
-
资金
- Investigator Initiated Studies Program (IISP) of Merck, Sharp Dohme (MSD)
- Gilead
- MSD
- Astellas
- Pfizer
- Bio-Rad
- Ferrer International
- Schering
- Innothera
To investigate azole resistance in clinical Aspergillus isolates, we conducted prospective multicenter international surveillance. A total of 3,788 Aspergillus isolates were screened in 22 centers from 19 countries. Azole-resistant A. fumigatus was more frequently found (3.2% prevalence) than previously acknowledged, causing resistant invasive and noninvasive aspergillosis and severely compromising clinical use of azoles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据